Y-mAbs Therapeutics (YMAB) Announces Dr. Gerard Ber to Board, Succeeding Dr. Michael Buschle
Tweet Send to a Friend
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) today announced the appointment of the molecular nuclear medicine executive, Dr. Gérard Ber, PhD to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
